Wikidata

(Q34371074)

English

Pomaglumetad methionil: no significant difference as an adjunctive treatment for patients with prominent negative symptoms of schizophrenia compared to placebo

scientific article

In more languages

Statements

title
Pomaglumetad methionil: no significant difference as an adjunctive treatment for patients with prominent negative symptoms of schizophrenia compared to placebo (English)
1 reference
stated in
Europe PubMed Central
PubMed ID
24035403
retrieved
1 August 2017
main subject
placebo
0 references
schizophrenia
0 references
author name string
Virginia L Stauffer
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed ID
24035403
retrieved
1 August 2017
Brian A Millen
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed ID
24035403
retrieved
1 August 2017
Scott Andersen
series ordinal
3
1 reference
stated in
Europe PubMed Central
PubMed ID
24035403
retrieved
1 August 2017
Bruce J Kinon
series ordinal
4
1 reference
stated in
Europe PubMed Central
PubMed ID
24035403
retrieved
1 August 2017
Lisa Lagrandeur
series ordinal
5
1 reference
stated in
Europe PubMed Central
PubMed ID
24035403
retrieved
1 August 2017
J P Lindenmayer
series ordinal
6
1 reference
stated in
Europe PubMed Central
PubMed ID
24035403
retrieved
1 August 2017
Juan Carlos Gomez
series ordinal
7
1 reference
stated in
Europe PubMed Central
PubMed ID
24035403
retrieved
1 August 2017
publication date
12 September 2013
1 reference
stated in
Europe PubMed Central
PubMed ID
24035403
retrieved
1 August 2017

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q34371074&oldid=1981034698"